Portland, OR -- (SBWIRE) -- 09/05/2017 -- Articaine hydrochloride is a local anaesthetic drug used for pain control by blocking nerve signals in the body. It is majorly used in dental procedures such as infiltration injection in the dental procedure.

Access to the full summary: https://www.alliedmarketresearch.com/articaine-hydrochloride-market

Increase in application of articaine hydrochloride owning to its quick effect and better efficacy than other anaesthetic drugs has fuelled the market growth. For instance, in patients with hypokalemic sensory overstimulation, articaine is more effective than lidocaine. Furthermore, the growing prevalence of dental disorders due to junk food and increasing geriatric population boost the articaine hydrochloride market. In addition, the increasing trend of cosmetic dentistry and rising disposable income are anticipated to boost the market growth. However, the high costs of dental procedures and unfavourable reimbursement policies are anticipated to hinder the market growth. Ongoing R&D activities related to articaine hydrochloride and dental procedures are anticipated to present new opportunities for the market.

Articaine Hydrochloride Market Key Segment:

By Application

- Infiltration
- Nerve Block
- Others

By End-User

- Dental Clinics
- Hospitals
- Academic & Research Institutes

Get sample PDF: https://www.alliedmarketresearch.com/request-toc-and-sample/3349

By Geography

North America

- U.S.
- Canada
- Mexico

Europe

- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe

Asia Pacific

- Japan
- China
- India
- Rest of Asia-Pacific

LAMEA

- Latin America
- The Middle East
- Africa

List of players profiled in the report

- Sanofi
- Novocol Healthcare Inc.
- Pierrel Group.
- Anhui BBCA Pharmaceutical Co., Ltd.
- Nortec Qumica S.A.
- Merck KGaA
- Siegfried Holding AG
- Septodont Healthcare India Pvt. Ltd.
- 3M Company
- Johnson & Johnson